iDayo Selects NXTM as Low Risk Investment

Call Now
800-993-0005

(^DJI) 0

0S&P 500 (^GSPC) 1320.68

1.82NASDAQ Composite (^IXIC) 2839.38

-10.74Russell 2000 (^RUT) 766.57

1.4

iDayo™ Stock Selector: NXTM - Nxstage Medical Inc

iDayo™ 10/30/06: Nxstage Medical Inc (NXTM) - 10/30/06

For the 16 week investment period starting 10/30/06 , the iDayo™ Stock Selector rated Nxstage Medical Inc (NXTM) as "Significant Accumulation" and selected NXTM as a buy for the investment period, identified as iDayo™ 10/30/06.

Company Profile for "Nxstage Medical Inc (NXTM)": NxStage Medical, Inc. engages in the development, manufactures, and marketing of systems for the treatment of end-stage renal disease and acute kidney failure primarily in the United States.

Google Finance History for NXTM

iDayo, Inc. (including its marketing professionals and staff), is not a registered Investment Advisor or Broker/Dealer, and does not provide investment advice or recommendations. Subscribers to iDayo™ are advised that the information, opinions, and analysis included in our web sites, on our free Educational Conference Calls, or in any other communication are based in good faith on sources believed to be reliable, but no representation or warranty, expressed or implied, is made as to their accuracy, completeness, or correctness.

Past performance is not necessarily indicative of the future performance of stocks posted. None of these postings, the iDayo™ system rating, nor any other information provided on our web sites, on our free Educational Conference Calls, or in any other communication constitutes a recommendation to buy or sell stocks or any other investment. Investing involves the risk of loss and Subscribers are urged to consult with their own independent financial advisors with respect to any investment.